Live from the NIH registry
Studies recruiting near Leesburg right now
Top 25 of 136 recruiting studies, sorted by proximity — each links to its official registry page
[18F]PI-2620 Phase 3 Histopathological Study
Alzheimer Disease
Phase 3
Interventional 200 participants sought
K2 Medical Research — Lady Lake, Florida (10.5 mi)
· Sponsor: Lantheus Biosciences Ltd.
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Clermont, Florida (16.8 mi)
· Sponsor: AstraZeneca
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Colitis Ulcerative
Phase 2
Interventional 204 participants sought
Novum Research- Site Number : 8400018 — Clermont, Florida (16.8 mi)
· Sponsor: Sanofi
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
ADARx Clinical Site — Wildwood, Florida (11.1 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Wildwood Clinical Research / Florida Retina Institute — Wildwood, Florida (11.1 mi)
· Sponsor: EyeBiotech Ltd.
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Clermont Oncology Center ( Site 0046) — Clermont, Florida (16.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 143 participants sought
Novum Research, LLC — Clermont, Florida (16.8 mi)
· Sponsor: Eli Lilly and Company
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
Nature Coast Clinical Research — Inverness, Florida (26.7 mi)
· Sponsor: Amgen
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — The Villages, Florida (12.2 mi)
· Sponsor: Axsome Therapeutics, Inc.
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
West Orange Endocrinology — Ocoee, Florida (25.4 mi)
· Sponsor: Amgen
Visugromab in Cachexia International Trial
Cancer-associated Cachexia
Phase 2, Phase 3
Interventional 518 participants sought
Clermont Oncology Center — Clermont, Florida (16.8 mi)
· Sponsor: CatalYm GmbH
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
Chronic Pain, Intractable Pain
N/A
Interventional 70 participants sought
Orlando Health Neuroscience Institute — Clermont, Florida (16.8 mi)
· Sponsor: Boston Scientific Corporation
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Alzheimer Disease, Dementia
Phase 3
Interventional 550 participants sought
Charter Research - The Villages — The Villages, Florida (12.2 mi)
· Sponsor: Eli Lilly and Company
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2
Interventional 325 participants sought
Advanced Urology Institute — Oxford, Florida (14.0 mi)
· Sponsor: CG Oncology, Inc.
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Health Central — Ocoee, Florida (25.4 mi)
· Sponsor: NRG Oncology
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Charter Research - Lady Lake — The Villages, Florida (12.2 mi)
· Sponsor: Bristol-Myers Squibb
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
K2 MEDICAL Research THE VILLAGES — Lady Lake, Florida (10.5 mi)
· Sponsor: Eli Lilly and Company
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Non Small Cell Lung Cancer
Phase 3
Interventional 630 participants sought
Florida Cancer Specialists -North - 1125 — The Villages, Florida (12.2 mi)
· Sponsor: OncoC4, Inc.
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Health Central — Ocoee, Florida (25.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Early Alzheimer's Disease
Phase 2
Interventional 340 participants sought
Charter Research - Lady Lake ( Site 1019) — The Villages, Florida (12.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Parkinson Disease
Phase 1
Interventional 127 participants sought
K2 Medical Research, LLC — The Villages, Florida (12.2 mi)
· Sponsor: Eli Lilly and Company
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Obesity or Overweight
Phase 3
Interventional 300 participants sought
Charter Research - The Villages — The Villages, Florida (12.2 mi)
· Sponsor: Amgen
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Malignant Neoplasm
Phase 2
Interventional 140 participants sought
Clermont Oncology Center ( Site 0041) — Clermont, Florida (16.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Clermont, Florida (16.8 mi)
· Sponsor: AstraZeneca
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women
Depressive Symptoms, Urinary Incontinence
N/A
Interventional 60 participants sought
Luxury Psychiatry Clinic — Winter Garden, Florida (23.4 mi)
· Sponsor: BTL Industries Ltd.